Recombinant Biotinylated Human VEGF R2/KDR Protein (Primary Amine Labeling) ,mFc Tag

Scan for product

抗体药物靶点研究

Product no.95412ES Sizes3 options SourceYeasen · Official

Cat. No. 95412ES25

现货 ¥2,285.00

Qty 1

Enquire now

Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status

95412ES25 25 μg ¥2,285.00 现货 Enquire

95412ES60 100 μg ¥6,885.00 现货 Enquire

95412ES76 500 μg ¥24,115.00 现货 Enquire

Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen

Cat.No95412ES

Purity> 95% as determined by SDS-PAGE and HPLC.

Specification25 μg

AppearanceLyophilized Powder

Storage-25 ~ -15℃保存，收到货之后有效期1年。复溶后，无菌条件下，-85 ~ -65℃保存，3个月有效期。

Shelf Life1年

Origin翌圣生物科技(上海)股份有限公司

应用方法 抗体药物靶点研究作为靶点蛋白用于抗体药物研发

适用物种种属人

检测方法 ELISA SDS-PAGE HPLC

生物特性参数 蛋白类型重组蛋白 种属来源人 生物活性描述ELISA Data: Immobilized Human VEGF165 No Tag at 2μg/ml (100μl/Well) on the plate. Dose response curve for Biotinylated Human VEGF R2 mFc Tag with the EC50 of 0.14μg/ml determined by ELISA. 应用抗体药物靶点研究

技术参数纯度> 95% as determined by SDS-PAGE and HPLC 内毒素水平< 1.0 EU per μg by the LAL method 分子量Predicted MW: 110 kDa; migrates to 135-160 kDa by SDS-PAGE due to glycosylation 制剂形式Lyophilized from 0.22μm filtered solution in PBS (pH 7.4) with 8% trehalose as protectant 储存条件-25 ~ -15℃保存，有效期1年；复溶后，-85 ~ -65℃无菌保存3个月 表达序列Ala20-Glu764 表达系统HEK293 标签C-mFc 外观Lyophilized Powder 复溶方法开盖前离心，使用蒸馏水复溶，浓度>100 μg/mL，建议分装避免反复冻融 Accession编号P35968-1 别名CD309 KDR VEGFR VEGFR2 VEGFR-21 FLK1 KRD1 Ly73